ScoreWhy is Traws Pharma, Inc. ?
1
The company has declared positive results for the last 2 consecutive quarters
- NET SALES(HY) At USD 2.73 MM has Grown at 2,297.37%
- ROCE(HY) Highest at 7,432.32%
- PRE-TAX PROFIT(Q) At USD -3.96 MM has Grown at 53.29%
2
With ROE of 1467.41%, it has a very attractive valuation with a 3.71 Price to Book Value
- Over the past year, while the stock has generated a return of -24.30%, its profits have risen by 386%
3
High Institutional Holdings at 26.27%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Traws Pharma, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Traws Pharma, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Traws Pharma, Inc.
-29.58%
-0.70
124.39%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.56%
EBIT Growth (5y)
-18.65%
EBIT to Interest (avg)
-21.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.66
Sales to Capital Employed (avg)
0.10
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.27%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
0
Industry P/E
Price to Book Value
3.71
EV to EBIT
-0.26
EV to EBITDA
-0.26
EV to Capital Employed
-5.57
EV to Sales
3.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
1467.41%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
NET SALES(HY)
At USD 2.73 MM has Grown at 2,297.37%
ROCE(HY)
Highest at 7,432.32%
PRE-TAX PROFIT(Q)
At USD -3.96 MM has Grown at 53.29%
NET PROFIT(Q)
At USD -3.03 MM has Grown at 64.22%
-2What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 101.05% (YoY
CASH AND EQV(HY)
Lowest at USD 19.5 MM
Here's what is working for Traws Pharma, Inc.
Net Sales
At USD 2.73 MM has Grown at 2,297.37%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD -3.96 MM has Grown at 53.29%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -3.03 MM has Grown at 64.22%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Here's what is not working for Traws Pharma, Inc.
Cash and Eqv
Lowest at USD 19.5 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 101.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
